The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Leptomeningeal metastases in the MRI era
Open accessAbstract
BACKGROUND: Diagnosis of leptomeningeal metastasis (LM) has become increasingly frequent. The diagnostic gold standard has been CSF cytology, but MRI is now used routinely for diagnosis. Diagnosis and prognosis of LM has not been studied in the MRI era. METHODS: Patients with LM from 2002 through 2004 were identified through a neurology database, as well as by reviewing all abnormal CSF cytologies from a pathology database. Diagnosis was made by malignant cytology or imaging; suspicious cases treated as LM were also included. RESULTS: A total of 187 patients with LM were analyzed in this retrospective review. Of these, 150 had solid and 37 had hematopoietic malignancies. Median age was 56.4 years, and median Karnofsky performance status (KPS) was 70. The most common types of solid tumor were breast (65 patients), lung (47), gastrointestinal (11), and melanoma (9). Of the hematopoietic tumors, 21 were lymphoma and 15 were leukemia. Fifty-three percent of patients were diagnosed by imaging, 23% by cytology, and 24% by both. Treatment included radiation therapy in 55%, intrathecal chemotherapy in 29%, and systemic chemotherapy in 18%; 21% received supportive care alone. Median overall survival was 2.4 (95% confidence interval 1.9-3.1) months. Median survival for patients with hematopoietic tumors was 4.7 months and for solid tumors was 2.3 months (p = 0.0006). In multivariate analysis, initial KPS and tumor type (solid vs hematopoietic) were significant predictors of survival. CONCLUSIONS: Despite enhanced diagnosis with MRI, prognosis remains poor in leptomeningeal metastasis. Those with hematopoietic tumors continue to fare better than those with solid tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients
Wasserstrom, W. R., Glass, J. P., & Posner, J. B. (1982) · Cancer · doi:10.1002/1097-0142(19820215)49:4<759::aid-cncr2820490427>3.0.co;2-7 · Cited by 1,124
Infiltration of the Leptomeninges by Systemic Cancer
Olson, M. E. (1974) · Archives of Neurology · doi:10.1001/archneur.1974.00490320010002 · Cited by 572
Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis
Freilich, R. J., Krol, G., & Deangelis, L. M. (1995) · Annals of Neurology · doi:10.1002/ana.410380111 · Cited by 412
Self-citationKaplan, J. G., DeSouza, T. G., Farkash, A., Shafran, B., Pack, D., Rehman, F., Fuks, J., & Portenoy, R. (1990) · Journal of Neuro-Oncology · doi:10.1007/bf02341153 · Cited by 308
Boogerd, W., van den Bent, M. J., Koehler, P. J., Heimans, J. J., van der Sande, J. J., Aaronson, N. K., Hart, A. A. M., Benraadt, J., & Vecht, C. J. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.08.012 · Cited by 286
Leptomeningeal metastasis: survival and prognostic factors in 155 patients
Herrlinger, U., Förschler, H., Küker, W., Meyermann, R., Bamberg, M., Dichgans, J., & Weller, M. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.05.008 · Cited by 173
Waki, F., Ando, M., Takashima, A., Yonemori, K., Nokihara, H., Miyake, M., Tateishi, U., Tsuta, K., Shimada, Y., Fujiwara, Y., et al. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9758-3 · Cited by 145
Jaeckle, K. A., Batchelor, T. T., O'Day, S. J., Phuphanich, S., New, P., Lesser, G. J., Cohn, A. L., Gilbert, M. R., Aiken, R. D., Heros, D. O., et al. (2002) · Journal of Neuro-Oncology · doi:10.1023/a:1015752331041 · Cited by 113
Diffuse involvement of the leptomeninges by tumour--a clinical and pathological study of 63 cases
Boyle, R., Thomas, M., & Adams, J. H. (1980) · Postgraduate Medical Journal · doi:10.1136/pgmj.56.653.149 · Cited by 111
Siegal, T. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1005999228846 · Cited by 86
Cited by
Le Rhun, E., Weller, M., Brandsma, D., Van den Bent, M., de Azambuja, E., Henriksson, R., Boulanger, T., Peters, S., Watts, C., Wick, W., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx221 · Cited by 637
Pentsova, E. I., Shah, R. H., Tang, J., Boire, A., You, D., Briggs, S., Omuro, A., Lin, X., Fleisher, M., Grommes, C., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.6487 · Cited by 417
Self-citationComplement Component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis.
Boire, A., Zou, Y., Shieh, J., Macalinao, D. G., Pentsova, E., & Massagué, J. (2017) · Cell · doi:10.1016/j.cell.2017.02.025 · Cited by 366
Carcinomatous meningitis: Leptomeningeal metastases in solid tumors
Chamberlain, M., Le Rhun, E., & Taillibert, S. (2013) · Surgical Neurology International · doi:10.4103/2152-7806.111304 · Cited by 338
Leptomeningeal metastases: a RANO proposal for response criteria
Chamberlain, M., Junck, L., Brandsma, D., Soffietti, R., Rudà, R., Raizer, J., Boogerd, W., Taillibert, S., Groves, M. D., Rhun, E. L., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now183 · Cited by 317
Metadata
- Authors
- Clarke, J. L., Perez, H. R., Jacks, L. M., Panageas, K. S., & DeAngelis, L. M.
- Venue
- Neurology
- Published
- 2010-05-04
- Volume
- 74
- Issue
- 18
- Pages
- 1449-1454
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2081302423
- Cited by
- 432
- References
- 10
- FWCI
- 14.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Leptomeningeal metastases in the MRI era. https://app.cochat.ai/papers/10.1212/wnl.0b013e3181dc1a69
- The paper
- Clarke, J. L., Perez, H. R., Jacks, L. M., Panageas, K. S., & DeAngelis, L. M. (2010). Leptomeningeal metastases in the MRI era. Neurology. https://doi.org/10.1212/wnl.0b013e3181dc1a69
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.